The potential value of natural antioxidative treatment in glaucoma - PubMed (original) (raw)
Review
The potential value of natural antioxidative treatment in glaucoma
M Mozaffarieh et al. Surv Ophthalmol. 2008 Sep-Oct.
Abstract
Glaucomatous optic neuropathy implies loss of retinal ganglion cells, including their axons, and a major tissue remodeling, especially in the optic nerve head. Although increased intraocular pressure is a major risk factor for glaucomatous optic neuropathy, there is little doubt that other factors such as ocular blood flow play a role as well. Mechanisms leading to glaucomatous optic neuropathy are not yet clearly understood. There is, however, increasing evidence that both an activation of glial cells and an oxidative stress in the axons play an important role. Glial cells may be activated by mechanical stress via activation of the epidermal growth-factor-receptor, or by ischemic stress via an increase in endothelin. Several factors can systemically or locally increase oxidative stress. In glaucoma, an unstable ocular blood flow leading to repeated mild reperfusion seems to be most relevant in inducing oxidative stress. The simultaneous production of nitric oxide in the astrocytes and of superoxide in the mitochondria of the axons leads to the production of the damaging peroxynitrite. Therapeutically, we need to reduce intraocular pressure, stabilize ocular blood flow, and reduce oxidative stress. Various natural compounds possess potential antioxidative value. Reduction of oxidative stress at the level of mitochondria can be achieved by gingko biloba. Polyphenolic compounds, such as tea, red wine, dark chocolate, or coffee have antioxidative properties. Coffee contains 3-methyl-1,2-cyclopentanedione (MCP), capable of scavenging peroxynitirite. Red wine-polyphenols (e.g., resveratrol), exert vasoprotective effects by inhibiting the synthesis of endothelin-1. Dark chocolate decreases blood pressure and improves endothelium-dependant vasorelaxation. Anthocyanosides (bilberries) owe their antioxidant effects to their particular chemical structure. Other antioxidants include ubiquinone and melatonin.
Similar articles
- Is there more to glaucoma treatment than lowering IOP?
Mozaffarieh M, Flammer J. Mozaffarieh M, et al. Surv Ophthalmol. 2007 Nov;52 Suppl 2:S174-9. doi: 10.1016/j.survophthal.2007.08.013. Surv Ophthalmol. 2007. PMID: 17998043 Review. - [Value of non-IOP lowering therapy for glaucoma].
Cybulska-Heinrich A, Mozaffarieh M, Flammer J. Cybulska-Heinrich A, et al. Klin Monbl Augenheilkd. 2013 Feb;230(2):114-9. doi: 10.1055/s-0032-1327825. Epub 2013 Feb 21. Klin Monbl Augenheilkd. 2013. PMID: 23430676 Review. German. - What is the present pathogenetic concept of glaucomatous optic neuropathy?
Flammer J, Mozaffarieh M. Flammer J, et al. Surv Ophthalmol. 2007 Nov;52 Suppl 2:S162-73. doi: 10.1016/j.survophthal.2007.08.012. Surv Ophthalmol. 2007. PMID: 17998042 Review. - Therapeutic potentials of aspirin in glaucomatous optic neuropathy.
Attarzadeh A, Hosseini H, Nowroozizadeh S. Attarzadeh A, et al. Med Hypotheses. 2006;67(2):375-7. doi: 10.1016/j.mehy.2006.01.033. Epub 2006 Mar 9. Med Hypotheses. 2006. PMID: 16527427 - Astrocytes in glaucomatous optic neuropathy.
Hernandez MR, Miao H, Lukas T. Hernandez MR, et al. Prog Brain Res. 2008;173:353-73. doi: 10.1016/S0079-6123(08)01125-4. Prog Brain Res. 2008. PMID: 18929121
Cited by
- Ocular oxidative changes and antioxidant therapy during spaceflight.
Masalkhi M, Ong J, Waisberg E, Lee AG. Masalkhi M, et al. Eye (Lond). 2024 Apr;38(6):1034-1035. doi: 10.1038/s41433-023-02841-0. Epub 2023 Nov 24. Eye (Lond). 2024. PMID: 38001279 No abstract available. - Green Tea Catechins as Therapeutic Antioxidants for Glaucoma Treatment.
Ng TK, Chu KO, Wang CC, Pang CP. Ng TK, et al. Antioxidants (Basel). 2023 Jun 21;12(7):1320. doi: 10.3390/antiox12071320. Antioxidants (Basel). 2023. PMID: 37507860 Free PMC article. Review. - Regulatory mechanisms of retinal ganglion cell death in normal tension glaucoma and potential therapies.
Shen WC, Huang BQ, Yang J. Shen WC, et al. Neural Regen Res. 2023 Jan;18(1):87-93. doi: 10.4103/1673-5374.344831. Neural Regen Res. 2023. PMID: 35799514 Free PMC article. Review. - Treatment of Glaucoma Patients with Flammer Syndrome.
Konieczka K, Flammer J. Konieczka K, et al. J Clin Med. 2021 Sep 17;10(18):4227. doi: 10.3390/jcm10184227. J Clin Med. 2021. PMID: 34575340 Free PMC article. Review. - A Review on Newer Ocular Drug Delivery Systems with an Emphasis on Glaucoma.
Peter M, Panonnummal R. Peter M, et al. Adv Pharm Bull. 2021 May;11(3):399-413. doi: 10.34172/apb.2021.048. Epub 2020 Sep 19. Adv Pharm Bull. 2021. PMID: 34513615 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous